This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Katelyn Smith, PhD
Senior Scientist at Merck & Co., Inc.


Katelyn Smith is a Sr. Scientist in at Merck & Co., Inc. in West Point, PA. Since joining Merck in the Preformulation group, she has supported the biophysical characterization and formulation screening of peptide- and RNA-based drug products. Prior to Merck, Katelyn received a B.S. in Chemistry from The College of New Jersey and a Ph.D. in Chemistry from the University of Delaware where she investigated the assembly mechanism and molecular-level structure of fibril-forming peptides.

Agenda Sessions

  • Learning Relationship between Chemical and Physical Stability of Peptides: Tools for Predicting Therapeutic Peptide Behavior during Drug Development


Speakers at this event